Wird geladen...
The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics
The current pandemic of coronavirus disease (COVID-19) caused by SARS-CoV-2 is a significant global health challenge. A recent study by Carvelli and colleagues now demonstrates the involvement of complement C5a and its receptor C5aR1 in disease progression and suggests that blockade of the C5a-C5aR1...
Gespeichert in:
| Veröffentlicht in: | Trends Immunol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Elsevier Ltd.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7510552/ https://ncbi.nlm.nih.gov/pubmed/33023856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.it.2020.09.008 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|